Themesothelioma News

Thursday, June 27, 2019

Drugs Approved for Melanoma - National Cancer Institute

Drugs Approved for Melanoma - National Cancer Institute

National Cancer Institute

Drugs Approved for Melanoma

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for melanoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in melanoma that are not listed here.

Drugs Approved for Melanoma

  • Aldesleukin
  • Binimetinib
  • Braftovi (Encorafenib)
  • Cobimetinib
  • Cotellic (Cobimetinib)
  • Dabrafenib Mesylate
  • Dacarbazine
  • Encorafenib
  • IL-2 (Aldesleukin)
  • Imlygic (Talimogene Laherparepvec)
  • Interleukin-2 (Aldesleukin)
  • Intron A (Recombinant Interferon Alfa-2b)
  • Ipilimumab
  • Keytruda (Pembrolizumab)
  • Mekinist (Trametinib)
  • Mektovi (Binimetinib)
  • Nivolumab
  • Opdivo (Nivolumab)
  • Peginterferon Alfa-2b
  • PEG-Intron (Peginterferon Alfa-2b)
  • Pembrolizumab
  • Proleukin (Aldesleukin)
  • Recombinant Interferon Alfa-2b
  • Sylatron (Peginterferon Alfa-2b)
  • Tafinlar (Dabrafenib Mesylate)
  • Talimogene Laherparepvec
  • Trametinib
  • Vemurafenib
  • Yervoy (Ipilimumab)
  • Zelboraf (Vemurafenib)
Related Resources
  • Skin Cancer (Including Melanoma)—Patient Version
  • Chemotherapy and You: Support for People With Cancer
  • Updated: June 10, 2019
EH at 10:03 AM
Share

No comments:

Post a Comment

‹
›
Home
View web version

About Me

EH
View my complete profile
Powered by Blogger.